|
Apr 14
|
Pfizer discontinues GLP-1 pill trial, stock trades flat
|
|
Apr 14
|
Three Stocks That May Be Trading Below Their Estimated Value In April 2025
|
|
Apr 11
|
Apple Stock’s Resilience Means This Is an Opportunity, Says BofA. Plus, Meta, Occidental, and More.
|
|
Apr 11
|
Why Eli Lilly and Company (LLY) Is the Best Medical Stock to Buy According to Billionaires
|
|
Apr 11
|
Eli Lilly Tries to Kill Custom Tirzepatide--But This Healthtech Rebel Isn't Backing Down
|
|
Apr 11
|
Novartis commits $23bn to US manufacturing amid tariff threats
|
|
Apr 11
|
Novo Remade Denmark. Then Came the Stock Selloff.
|
|
Apr 11
|
FASB sets clock for derivatives rules update
|
|
Apr 11
|
Eli Lilly Challenges Custom Tirzepatide--But This Healthtech Startup Is Fighting Back
|
|
Apr 11
|
Zealand Pharma Goes on Hiring Spree as It Gears Up for Obesity Tie-Up With Roche
|
|
Apr 11
|
Wall Street Pulls Back on the Weight-Loss Drug Hype
|
|
Apr 11
|
The Zacks Analyst Blog Highlights Eli Lilly, American Express, Thermo Fisher, Steel Partners and Oil-Dri
|
|
Apr 11
|
How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs
|
|
Apr 11
|
Pharma’s US manufacturing moment: Where companies are making the biggest moves
|
|
Apr 10
|
Top Research Reports for Eli Lilly, American Express & Thermo Fisher
|
|
Apr 10
|
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
|
|
Apr 10
|
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
|
|
Apr 10
|
Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs
|
|
Apr 10
|
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks
|
|
Apr 10
|
Trump’s tariff tirade and sudden calm keep Big Pharma on its toes
|